| Asking Price: |
Undisclosed |
| Revenue: |
$967,032
(USD)
|
| Cash Flow: |
$430,414
(USD)
|
Sale Pending! HemoGenix, Inc. (HG), founded in 2000, remains a significant entity in the stem cell assay market. The company has developed proprietary toxicology testing procedures that have been... More details »